81 related articles for article (PubMed ID: 1305958)
21. Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
Poisson D; Christen MO; Sannajust F
J Pharmacol Exp Ther; 2000 Jun; 293(3):929-38. PubMed ID: 10869394
[TBL] [Abstract][Full Text] [Related]
22. Sedative action of some substituted benzylamides.
Sethi OP; Gupta MV; Bhatia OS; Derasari HR
Indian J Physiol Pharmacol; 1977; 21(1):1-10. PubMed ID: 873586
[TBL] [Abstract][Full Text] [Related]
23. Esters of 7-(diphenylmethylene)bicyclo[2.2.1]heptan-2-endo-ol with antiarrhythmic and other activities.
Longobardi M; Bargagna A; Mariani E; Schenone P; Russo S; De Paola C; Stella L; Donnoli D; Falzarano C; Marmo E
Farmaco; 1991 May; 46(5):647-56. PubMed ID: 1953925
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, physicochemical and preliminary pharmacological properties of N-[beta-hydroxy-gamma-(N-phenylpiperazinepropyl)]-2-pyrrolidinone.
Malawska B; Gorczyca M; Filipek B
Pol J Pharmacol Pharm; 1992; 44(6):561-74. PubMed ID: 1305957
[TBL] [Abstract][Full Text] [Related]
27. (RS), (R)(-) and (S)(+) derivatives of 2-N-arylalkylamino-1-butanol having antiarrhythmic properties.
Eckstein M; Zajaczkowska J; Samochowiec L
Pol J Pharmacol Pharm; 1988; 40(4):401-11. PubMed ID: 3222179
[TBL] [Abstract][Full Text] [Related]
28. [Observation of antiarrhythmic effects of Cinnamomum migao H. W. Li on experimental arrhythmia].
Sui Y; Qiu D; Xie C; Chen K
Zhongguo Zhong Yao Za Zhi; 1998 Aug; 23(8):495-7, inside back cover. PubMed ID: 11599375
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of local anesthetic effects on artificial membranes and isolated cardiac tissues.
Schlieper P
Arzneimittelforschung; 1984; 34(7):759-61. PubMed ID: 6541911
[TBL] [Abstract][Full Text] [Related]
30. Derivatives of 2-mercaptobenzenesulphonamide. XX. Synthesis and cardiovascular effects of some 2-[4-chloro-2-(2-dialkylaminoethylthio)-5-methylbenzenesulphonylimino]- perhydropyrimidines.
Pomarnacka E; Oledzka K
Acta Pol Pharm; 1996; 53(6):443-7. PubMed ID: 9415219
[TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
[TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic effect of some naphthylalkylamine derivatives.
Hadházy P; Kecskeméti V; Vizi ES; Illés P
Acta Physiol Acad Sci Hung; 1968; 33(2):185-95. PubMed ID: 5679793
[No Abstract] [Full Text] [Related]
33. Derivatives of (R,S)-1-N-(theophyllinyl-7'-ethyl)-amino-2-propanol with antiarrhythmic activity.
Eckstein M; Zajaczkowska J; Samochowiec L; Maksjan M
Pol J Pharmacol Pharm; 1990; 42(4):387-92. PubMed ID: 2097599
[TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic activity of the local anaesthetic fomocaine and some of its analogues.
Bräunig B; Busch AE; Mutschler E; Wess J; Oelschläger H
Arzneimittelforschung; 1989 Nov; 39(11):1436-9. PubMed ID: 2619777
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological activity of 1-isopropylamino-3-(1-naphthylamino)-2-propanol, an analogue of propranolol.
Daniewski W; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):23-8. PubMed ID: 4775863
[No Abstract] [Full Text] [Related]
36. [Antiarrhythmic effects of kappa-seleno-carrageenan in experimental animals].
Li D; Yang XY; Han Q; Xi BB; Xie P; Lin ZJ
Yao Xue Xue Bao; 1992; 27(10):725-8. PubMed ID: 1338176
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and properties of some aminoalkanolic derivatives of xanthone.
Marona H; Szneler E; Filipek B; Sapa J
Acta Pol Pharm; 1997; 54(1):63-70. PubMed ID: 9415200
[TBL] [Abstract][Full Text] [Related]
38. [Experimental arrhythmia and its prevention].
Stazhadze LL; Ventslavskaia TA; Korzhova VV
Kosm Biol Aviakosm Med; 1985; 19(6):64-8. PubMed ID: 4087865
[TBL] [Abstract][Full Text] [Related]
39. Derivatives of 2-N-arylalkylamino-2-methyl-1-propanol with antiarrhythmic activity.
Eckstein M; Zajaczkowska J; Krupińska J; Michna M
Pol J Pharmacol Pharm; 1986; 38(2):215-20. PubMed ID: 3748893
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
Darias V; del Río J
Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
